☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Merck Reports Results of Keytruda (pembrolizumab) in P-III KEYNOTE-240 Study for 1L Advanced Hepatocellular Carcinoma (HCC)
February 21, 2019
Mustang Bio Signs an Exclusive Worldwide Collaboration with Nationwide Children's Hospital for Glioblastoma Multiforme
February 21, 2019
Novo Nordisk Signs Non -Exclusive Agreement with Abbott for its FreeStyle Libre Mobile App
February 21, 2019
AbbVie's Humira (adalimumab) Receives Health Canada Approval for Chronic Non-Infectious Anterior Uveitis in Pediatric Patients
February 21, 2019
Merck to Acquire Immune Design for its Technologies for $300M
February 21, 2019
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions